Suma Ramadas, PhDMedical Affairs
Liz KaneImpactful Strategy
Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
Matt TurnerPatient Affordability
Bud BilanichSuccess Coach
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Joey CohenMedication Adherence
Paul TheisenPatient Acquisition
Brenda SnowAuthentic Patient Voice
David LinetskyPoint-of-Care Marketing
NEWARK, Calif., March 28, 2016 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), today announced ...
– FCX-007 well-tolerated through 12 weeks post-administration with encouraging safety and positive early trends ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email
